Ivan Peñuelas Selected Research

Ivan Peñuelas Research Topics

4	Neoplasms (Cancer) 09/2018 - 05/2010
2	Ischemia 03/2015 - 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 01/2023
1	Acute Intermittent Porphyria (Porphyria, Acute) 01/2023
1	Insulin Resistance 01/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 09/2022
1	Peanut Hypersensitivity (Peanut Allergy) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2012
1	Atrophy 09/2012
1	Cognitive Dysfunction 09/2012
1	Residual Neoplasm 12/2011
1	Necrosis 01/2011
1	Fibrosis (Cirrhosis) 01/2011
1	Neoplasm Metastasis (Metastasis) 05/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2010
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Lung Neoplasms (Lung Cancer) 05/2010

1	Drinking WaterIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Heme (Haem)IBA 01/2023
1	CarbohydratesIBA 01/2023
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 01/2023
1	EnzymesIBA 01/2023
1	CopperIBA 09/2022
1	ResveratrolIBA 09/2018
1	PolyphenolsIBA 09/2018
1	matrigelIBA 03/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2015
1	Flumazenil (Romazicon)FDA LinkGeneric 09/2012
1	Amyloid (Amyloid Fibrils)IBA 09/2012
1	gamma-Aminobutyric Acid (GABA)IBA 09/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	Poly I-CIBA 12/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2011
1	Epidermal Growth Factor (EGF)IBA 05/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2010
1	Tyrosine Kinase InhibitorsIBA 05/2010
1	Lapatinib (GW572016)FDA Link 05/2010
1	Gefitinib (Iressa)FDA Link 05/2010